Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk

医学 累积发病率 内科学 危险系数 比例危险模型 骨髓增生异常综合症 人口 炎症性肠病 入射(几何) 髓系白血病 队列 置信区间 疾病 骨髓 光学 物理 环境卫生
作者
Nabeel Khan,Dhruvan Patel,Chinmay Trivedi,Himanshu Kavani,Tyler Pernes,Elina Medvedeva,James D. Lewis,Dawei Xie,Yu‐Xiao Yang
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:116 (4): 741-747 被引量:27
标识
DOI:10.14309/ajg.0000000000001058
摘要

INTRODUCTION: Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are rare myeloid clonal disorders that commonly affect the elderly population and have poor prognosis. There are limited data on the risk of AML/MDS among patients with inflammatory bowel disease (IBD), especially on the impact of thiopurines (TPs). METHODS: We conducted a retrospective cohort study among patients with IBD from Veteran Affairs data set. The exposure of interest was TP exposure: (i) never exposed to TPs, (ii) past TP use (discontinued >6 months ago), (iii) current TP use with a cumulative exposure of <2 years, and (iv) current TP use with a cumulative exposure of ≥2 years. The outcome of interest was a composite outcome of incident diagnosis of AML and/or MDS. Cox regression was used to estimate the adjusted and unadjusted hazard ratios (HRs) with 95% confidence intervals (CIs) for AML/MDS risk associated with TP use defined as a time-varying exposure. RESULTS: Among 56,314 study patients, 107 developed AML/MDS. The overall incidence of AML/MDS in the IBD population was 18.7 per 100,000 patient-years. The incidences among those never exposed to TPs, past users of TPs, current users of TPs with a cumulative exposure of <2 years, and current users of TPs with a cumulative exposure of ≥2 years were 17.0, 17.7, 30.4, and 30.3 per 100,000 patient-years, respectively. In multivariable Cox regression analysis, compared with never exposed to TPs, current use of TPs was associated with increased risk (adjusted HR 3.05; 95% CI 1.54–6.06, P = 0.0014 for current use of TPs with a cumulative exposure of <2 years and adjusted HR 2.32; 95% CI 1.22–4.41, P = 0.0101 for current use of TPs with a cumulative exposure of ≥2 years), whereas past TP exposure was not. DISCUSSION: Among patients with IBD, current TP use was associated with an increased risk of AML/MDS, which reverts to baseline after discontinuation of TP use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
灵巧小笼包完成签到 ,获得积分10
1秒前
完美世界的应助被Pisces采纳,获得10
1秒前
2秒前
上官若男的应助被摇钱树采纳,获得10
2秒前
2秒前
Zz完成签到,获得积分10
3秒前
小马甲的应助被木木采纳,获得10
3秒前
3秒前
逃跑计划完成签到,获得积分10
4秒前
郭姗姗发布了新的文献求助10
4秒前
小二郎的应助被qh采纳,获得10
5秒前
李李发布了新的文献求助10
5秒前
Xh的应助被科研通管家采纳,获得10
5秒前
SciGPT的应助被科研通管家采纳,获得10
6秒前
JamesPei的应助被科研通管家采纳,获得10
6秒前
Owen的应助被科研通管家采纳,获得10
6秒前
爆米花的应助被科研通管家采纳,获得10
6秒前
李爱国的应助被科研通管家采纳,获得10
6秒前
在水一方的应助被科研通管家采纳,获得10
6秒前
6秒前
molihuakai的应助被科研通管家采纳,获得10
7秒前
7秒前
NexusExplorer的应助被敏感墨镜采纳,获得10
7秒前
7秒前
7秒前
Hello的应助被科研通管家采纳,获得10
7秒前
爆米花的应助被科研通管家采纳,获得10
7秒前
英俊的铭的应助被科研通管家采纳,获得10
7秒前
Re0pen发布了新的文献求助10
7秒前
Chem完成签到,获得积分10
7秒前
小二郎的应助被科研通管家采纳,获得10
7秒前
7秒前
在水一方的应助被科研通管家采纳,获得10
7秒前
7秒前
小二郎的应助被科研通管家采纳,获得10
8秒前
星辰大海的应助被科研通管家采纳,获得10
8秒前
秋风的应助被科研通管家采纳,获得20
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184156
求助须知:如何正确求助?哪些是违规求助? 9573231
关于积分的说明 21830220
捐赠科研通 7781184
什么是DOI,文献DOI怎么找? 3434230
关于科研通互助平台的介绍 2558353
邀请新用户注册赠送积分活动 2480728